Olivia Campagne

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Phase II study of alisertib as a single agent in recurrent or progressive atypical teratoid rhabdoid tumors.”.

Phase II study of alisertib as a single agent in recurrent or progressive atypical teratoid rhabdoid tumors.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.10542

N/A

0DataRank · unranked

9 citations

Olivia Campagne, Giles Robinson, Arzu Onar‐Thomas, Brent A. Orr, Catherine A. Billups +12 more

A phase I trial of the CDK 4/6 inhibitor palbociclib in pediatric patients with progressive brain tumors: a Pediatric Brain Tumor Consortium study (PBTC-042)

(2020)10.22541/au.160218216.66566554/v1

N/A

0DataRank · unranked

3 citations

Sridharan Gururangan, Oren J. Becher, Olivia Campagne, Sarah Leary, Joanna J. Phillips +14 more

Correction to: Pharmacokinetics and safety of erlotinib and its metabolite OSI-420 in infants and children with primary brain tumors

Cancer Chemotherapy and Pharmacology(2020)10.1007/s00280-019-04026-7

N/A

0DataRank · unranked

0 citations

Olivia Campagne, Jie Huang, Arzu Onar‐Thomas, Alberto Broniscer, Amar Gajjar +2 more

A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1: a Pediatric Brain Tumor Consortium study

Neuro-Oncology(2021)10.1093/neuonc/noab047

N/A

0DataRank · unranked

159 citations

Arzu Onar‐Thomas, Tina Young Poussaint, Shengjie Wu, Azra H. Ligon, Neal I. Lindeman +18 more

Phase I study using crenolanib to target PDGFR kinase in children and young adults with newly diagnosed DIPG or recurrent high-grade glioma, including DIPG

Neuro-Oncology Advances(2021)10.1093/noajnl/vdab179

N/A

0DataRank · unranked

20 citations

Alberto Broniscer, Jason Chiang, Olivia Campagne, Jie Huang, Brent A. Orr +11 more

Phase II study of alisertib as a single agent for treating recurrent or progressive atypical teratoid/rhabdoid tumor

Neuro-Oncology(2022)10.1093/neuonc/noac151

N/A

0DataRank · unranked

30 citations

Olivia Campagne, Catherine A. Billups, Brent A. Orr, Arzu Onar‐Thomas, Ruth G. Tatevossian +23 more

Combination of Ribociclib and Gemcitabine for the Treatment of Medulloblastoma

Molecular Cancer Therapeutics(2022)10.1158/1535-7163.mct-21-0598

N/A

0DataRank · unranked

12 citations

Barbara Jonchère, Jingjing Liu, Kyle Smith, Olivia Campagne, Ke Xu +10 more

Population pharmacokinetics of methotrexate and 7-hydroxymethotrexate and delayed excretion in infants and young children with brain tumors

European Journal of Pharmaceutical Sciences(2023)10.1016/j.ejps.2023.106669

N/A

0DataRank · unranked

8 citations

Jie Huang, Tong Lin, Wilburn E. Reddick, Nicholas S. Selvo, Arzu Onar‐Thomas +5 more

Topotecan clearance based on a single sample and a population pharmacokinetic model: Application to a pediatric high‐risk neuroblastoma clinical trial

Pediatric Blood & Cancer(2023)10.1002/pbc.30658

N/A

0DataRank · unranked

0 citations

Huiyun Wu, Jianrong Wu, Arlene Naranjo, Vinay M. Daryani, Amar Gajjar +3 more